Telos RX is a telehealth platform offering compounded GLP-1 weight-loss programs — with a notable twist: alongside the standard injection, it offers a needle-free oral tirzepatide. This review covers how it works, pricing, what stands out, the trust signals worth knowing, and who it suits best.
Quick verdict: Telos RX is the pick if you're focused on tirzepatide or want to avoid needles — its needle-free oral tirzepatide (with built-in anti-nausea) is genuinely differentiated. Pricing starts around $129/month, it's fulfilled through licensed 503A pharmacies with a board-certified team, and it adds pay-over-time financing. As with any compounded program, it isn't FDA-approved, and a licensed provider decides whether it's appropriate for you.
What is Telos RX?
Telos RX is an online telehealth service connecting patients with U.S.-licensed providers for compounded medications, with a primary focus on GLP-1 weight loss (compounded tirzepatide and semaglutide). It also offers a broader wellness catalog including options like NAD+ and sermorelin. As with all compounded programs, it's worth stating clearly: compounded medications are not FDA-approved, and the FDA does not evaluate them for safety, effectiveness, or quality before use.
How Telos RX works
- Online assessment — a short health questionnaire about your history and goals.
- Provider review — a licensed provider reviews your profile and decides what, if anything, is appropriate. Not everyone qualifies.
- Pharmacy fulfillment — if prescribed, a licensed 503A pharmacy prepares the medication; Telos RX advertises free 48-hour shipping.
- Ongoing support — 24/7 provider messaging for refills and adjustments.
Telos RX pricing
Compounded tirzepatide starts around $139/month for the injectable and $129/month for the needle-free oral version; semaglutide is also offered. Pricing is flat across dose adjustments, shipping is included, and it's FSA/HSA eligible. Telos RX also offers pay-over-time options (Affirm, Afterpay, Klarna), which can help spread the cost. Prices are set by the platform and can change.
What we like — and what to consider
What stands out
- Needle-free oral tirzepatide (anti-nausea built in)
- Injectable tirzepatide & semaglutide too
- Flat pricing across dose changes
- Licensed 503A pharmacy; board-certified team
- Free 48-hour shipping; 24/7 messaging
- Pay-over-time (Affirm, Afterpay, Klarna); FSA/HSA
Things to consider
- Entry price higher than the cheapest options
- Compounded medications aren't FDA-approved
- Requires provider approval — not everyone qualifies
Is Telos RX legit?
On the usual trust checks, Telos RX connects you with U.S.-licensed providers, works with a board-certified medical team, and fills through licensed 503A pharmacies — the markers of a legitimate telehealth operation. The category-wide caveat still applies: compounded medications are not FDA-approved, and whether one is appropriate for you is a decision made by your provider, not by a platform or a review.
Who Telos RX is best for
Telos RX fits best if you specifically want tirzepatide, prefer a needle-free oral option, or want financing flexibility. If the lowest possible entry price is your priority, a cheaper semaglutide option may suit you better — see our comparison of the best compounded GLP-1 programs or the Trimi vs Telos RX head-to-head.
Telos RX FAQ
How much does Telos RX cost?
Compounded tirzepatide starts around $139/month (injectable) or $129/month (oral), with flat pricing across dose adjustments. Prices are set by Telos RX and can change.
Does Telos RX have a needle-free option?
Yes. Telos RX offers a needle-free daily oral tirzepatide, formulated with ondansetron (an anti-nausea medication), in addition to the standard weekly injection.
Is Telos RX FDA-approved?
Telos RX provides access to compounded medications, which are not FDA-approved. The FDA does not evaluate compounded drugs for safety, effectiveness, or quality before use. It uses licensed providers and 503A pharmacies.
Do I need a prescription?
Yes. A licensed provider reviews your online assessment and decides whether a program is appropriate. Not everyone qualifies.